CD274 and cancer: Being a pioneer of CIK cell therapy (30), we have already demonstrated the favorable effect of CIK cells with known cancer inhibitors (e.g. PD-1/PD-L1) (31) and even epigenetic compounds (e.g. HDAC) (32).